Abstract
Sustained-release floating drug delivery systems (FDDSs) enable prolonged and continuous input of the drug to the upper parts of the gastrointestinal tract have been designed and fabricated using three dimensional printing (3DP) technology. A new strategy is proposed for the development of FDDSs. The design of FDDSs was based on the sustained release formulation, with low density and floating features in order to prolong the gastric retention time, with special surface textures and variations of drug distribution in the FDDSs for constant release profiles. The local variations of drug in the FDDSs were traced by methylene blue. To measure the floating force, a novel apparatus was developed. Duration of buoyancy and drug release profiles were determined in vitro. It was found that FDDSs were able to float on the dissolution medium 12h, which was the whole tests time periods, and free out the model drug metformin hydrochloride in a way of near zero-order kinetics. 3DP is able to offer possibility for developing FDDSs with complicated design features for providing long-time gastro-retention and desired drug release profiles.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
